1. Home
  2. LEE vs CLSD Comparison

LEE vs CLSD Comparison

Compare LEE & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • CLSD
  • Stock Information
  • Founded
  • LEE 1890
  • CLSD 2011
  • Country
  • LEE United States
  • CLSD United States
  • Employees
  • LEE N/A
  • CLSD N/A
  • Industry
  • LEE Newspapers/Magazines
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • CLSD Health Care
  • Exchange
  • LEE Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • LEE 90.6M
  • CLSD 81.2M
  • IPO Year
  • LEE N/A
  • CLSD 2016
  • Fundamental
  • Price
  • LEE $10.44
  • CLSD $0.95
  • Analyst Decision
  • LEE
  • CLSD Strong Buy
  • Analyst Count
  • LEE 0
  • CLSD 6
  • Target Price
  • LEE N/A
  • CLSD $5.33
  • AVG Volume (30 Days)
  • LEE 19.1K
  • CLSD 214.9K
  • Earning Date
  • LEE 02-06-2025
  • CLSD 03-11-2025
  • Dividend Yield
  • LEE N/A
  • CLSD N/A
  • EPS Growth
  • LEE N/A
  • CLSD N/A
  • EPS
  • LEE N/A
  • CLSD N/A
  • Revenue
  • LEE $600,264,000.00
  • CLSD $7,703,000.00
  • Revenue This Year
  • LEE N/A
  • CLSD N/A
  • Revenue Next Year
  • LEE N/A
  • CLSD $91.87
  • P/E Ratio
  • LEE N/A
  • CLSD N/A
  • Revenue Growth
  • LEE N/A
  • CLSD 248.39
  • 52 Week Low
  • LEE $7.57
  • CLSD $0.80
  • 52 Week High
  • LEE $19.63
  • CLSD $2.12
  • Technical
  • Relative Strength Index (RSI)
  • LEE 25.74
  • CLSD 43.06
  • Support Level
  • LEE $11.11
  • CLSD $1.00
  • Resistance Level
  • LEE $11.69
  • CLSD $1.09
  • Average True Range (ATR)
  • LEE 0.62
  • CLSD 0.07
  • MACD
  • LEE -0.10
  • CLSD -0.01
  • Stochastic Oscillator
  • LEE 6.16
  • CLSD 16.30

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: